Documentos relacionados

1. High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors.
2. Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions.
3. Fatal hemolytic disease of the newborn due to anti-B Isohemagglutinin: An unfamiliar presentation of a familiar disease.
4. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
5. A2/A2B to B kidney transplantation outcomes: A single center 7-year experience.
6. The monocyte monolayer assay, an <i>in vitro</i> method for prediction of <i>in vivo</i> survival of transfused incompatible red blood cells: a review.
7. Clinical significance of IgM and IgG isoagglutinins in ABO-incompatible solid organ transplantation: Insights from materno-fetal immunoglobulin status.
8. Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn.
9. Isohemagglutinin titering performed on an automated solid-phase and hemagglutinin-based analyzer is comparable to results obtained by manual gel testing.
10. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.